The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 09, 2015
Filed:
Jul. 06, 2012
Applicants:
David Michael Evans, Salisbury, GB;
Rebecca Louise Davie, Salisbury, GB;
Hannah Joy Edwards, Salisbury, GB;
David Philip Rooker, Salisbury, GB;
Inventors:
David Michael Evans, Salisbury, GB;
Rebecca Louise Davie, Salisbury, GB;
Hannah Joy Edwards, Salisbury, GB;
David Philip Rooker, Salisbury, GB;
Assignee:
KalVista Pharmaceuticals Limited, Wiltshire, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 333/38 (2006.01); C07D 207/16 (2006.01); C07D 213/81 (2006.01); C07D 215/48 (2006.01); C07D 261/18 (2006.01); C07C 237/20 (2006.01); C07C 317/28 (2006.01); C07C 237/22 (2006.01); C07K 5/062 (2006.01); C07K 5/06 (2006.01); C07K 5/065 (2006.01); C07D 231/14 (2006.01); C07D 333/24 (2006.01); C07D 333/60 (2006.01); C07D 233/90 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 207/34 (2006.01); C07D 277/30 (2006.01); C07D 277/56 (2006.01); C07D 209/18 (2006.01); C07D 213/56 (2006.01); C07D 307/68 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07C 317/28 (2013.01); C07C 237/22 (2013.01); C07D 207/16 (2013.01); A61K 38/00 (2013.01); C07K 5/06026 (2013.01); C07K 5/06191 (2013.01); C07K 5/06078 (2013.01); C07K 5/06034 (2013.01); C07D 213/81 (2013.01); C07D 215/48 (2013.01); C07D 231/14 (2013.01); C07D 333/24 (2013.01); C07D 333/38 (2013.01); C07D 333/60 (2013.01); C07D 233/90 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 261/18 (2013.01); C07D 207/34 (2013.01); C07D 277/30 (2013.01); C07D 277/56 (2013.01); C07D 209/18 (2013.01); C07D 213/56 (2013.01); C07D 307/68 (2013.01); C07K 5/06 (2013.01); C07C 237/20 (2013.01);
Abstract
The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein Rto Rare as defined herein.